B O O K - American College of Rheumatology

abstract KEYWORD INDEX
NOD2 gene mutation 1656
nod-like receptor (NLR) 1713, 2226
nominal group technique (NGT) 2196
nonalcoholic fatty liver disease 1666
non-attendance 1007
non-cardiovascular disease 49
non-Hodgkin´s lymphoma 1913
non-inflammatory symptoms 990
non-invasive 647
nonoparticles of LDE 284
nonrestful sleep 820
nonsteroidal antiinflammatory drugs (NSAIDs)
151, 882, 942, 945, 946, 954, 955, 1477, 2205,
2206
north and south 783
north India 4
NOS3 1352
novel cardiovascular risk factors 1067
novel therapeutic 2032
NSAIDs 298
NT-proBNP 483, 1059
nuclear hormone receptor 611
nuclear receptor 1387, 1481
nurse perspective 2279
nursing consultations 2280
nutrition 1366
NZB/W mice 1414
obesity 95, 179, 231, 297, 515, 627, 685, 939,
1330, 1331, 1364, 1562, 2257
observational 405, 1036
observational study 1381
obstetrical outcomes 775
occupational therapy 1319, 2050, 2063, 2143
ocrelizumab 383, 414, 1455, 2169
ocular involvement 240, 256, 512, 1405, 1670
odontostomatologic involvement 1687
older adults 692, 2071
Olf1/EBF associated zinc finger protein 1182
oncostatin M 30
online resources 1345
onycholysis 1951
open label 97
open, randomized trial 891
opportunistic infections 472, 700, 1310, 1643
opsonisation 490
optimally effective MTX dose 388
optimising health care resources 776, 1553
oral 1074, 1716
oral microbiota 1390
organ involvement 578
orthopedic 1381, 1576
O
orthopedic surgery 1550, 1570
osteoarthritis 37, 46, 121, 122, 124, 128, 131,
137, 140, 142, 143, 167, 168, 169, 171, 176,
178, 179, 180, 181, 184, 185, 186, 187, 188,
189, 190, 191, 193, 194, 195, 196, 197, 200,
201, 202, 203, 204, 205, 624, 631, 632, 633,
634, 682, 683, 684, 685, 686, 692, 693, 706,
707, 708, 709, 710, 711, 823, 831, 835, 838,
840, 841, 845, 875, 936, 937, 938, 939, 940,
941, 942, 943, 944, 948, 949, 950, 951, 952,
953, 954, 955, 963, 1319, 1373, 1380, 1382,
1384, 1426, 1463, 1464, 1472, 1476, 1477,
1480, 1484, 1486, 1489, 1494, 1497, 1503,
1532, 1555, 1557, 1558, 1620, 1628, 2051,
2052, 2055, 2056, 2058, 2091, 2092, 2093,
2094, 2096, 2097, 2098, 2099, 2100, 2101,
2132, 2133, 2134, 2136, 2140, 2205, 2211,
2229, 2244
osteoblasts 630, 716, 881, 956, 1487, 1490
osteoclast differentiation and bone turnover
1471
osteoclast inhibition 273
osteoclast-mediated bone resorption 1470
osteoclastogenesis 281, 353, 365, 677, 1130,
1467, 1469, 1488, 1492, 1493, 1495, 2237
osteoclasts 22, 521, 639, 677, 842, 1351, 1471,
1485, 1492, 1493, 1502, 2158
osteocytes 965
osteolysis 1080
osteomalacia 2082
osteonecrosis 1653, 2213
osteopenia 964, 1770
osteophytosis 185, 1373
osteopontin 262, 612, 1521, 2170
osteoporosis 31, 798, 956, 957, 958, 960, 961,
966, 967, 968, 969, 970, 972, 974, 976, 977,
978, 980, 982, 983, 989, 994, 999, 1005, 1006,
1066, 1156, 1316, 1317, 1318, 1540, 1543,
1552, 1561, 1773, 2112, 2157, 2159, 2161
osteoprotegerin 479, 623, 1017, 1497
outcome 1315, 1626, 1736
outcome measures 79, 107, 108, 117, 142, 143,
181, 217, 227, 306, 337, 567, 570, 577, 586,
599, 769, 772, 777, 795, 800, 920, 1014, 1112,
1157, 1213, 1284, 1303, 1316, 1369, 1463,
1545, 1559, 1668, 1683, 1688, 1700, 1745,
1766, 1787, 1809, 1863, 1878, 1896, 1922,
2091, 2095, 2137, 2222, 2225, 2280
outcome studies 651
outcomes 705, 1747
outdoor falls 684
over dispersion 1564
oxidative damage 360
oxidative stress 621, 631, 1357
oxoguanine 631
P selectin 492
p21 861
P
P2Y12 10
p38 32, 274, 1513
p38 MAPK 1119
paced visual serial adding test (PVSAT) 1167
Paget 975, 2237
PAH 402
PAH-QuERI 598
pain 79, 96, 97, 151, 170, 173, 174, 184, 647,
682, 785, 809, 810, 814, 819, 821, 823, 836,
841, 936, 939, 949, 950, 951, 1050, 1063, 1343,
1385, 1464, 1551, 1557, 1567, 1568, 1645,
1665, 1703, 1778, 1862, 1882, 2058, 2097,
2098, 2245, 2247, 2248, 2249
pain measures 2244
pamidronate 1925
pandemic 478
pandemic H1N1 influenza 323
papillary thyroid cancer 1038
paradoxical effect 904
parathyroid hormone 2160
parenteral 396
parotid gland 1887
PARP-1 440
Parry-Romberg syndrome 1687
parvovirus B19 694, 1641
PASE questionnaire 1937
patellofemoral joint 2244
path analysis 819
pathergy phenomenon 1289
pathergy test 1289
pathogen-associated molecular pattern 1446
pathogenesis 1374, 1971, 1993
pathology 367
patient care 1335
patient characteristics 68
patient doctor communication 1428
patient global assessment 79, 166
patient global impression of change 814, 950
patient organizations 1923
patient outcomes 1735
patient perception 998
patient preferences 324
patient questionnaires 63, 69, 84, 115, 178,
802, 985, 990, 1007, 1027, 1303, 1750, 1755,
1857, 1910, 2066, 2068
patient satisfaction 177, 1002
patient specific functional scale 115
pattern 1769
pattern recognition receptors 2230
pDC 494
PDGF receptor 2001
PDGFR inhibitor 289
pediatric 1305, 2017
pediatric Behçet’s disease 1305
pediatric rheumatology 4, 47, 211, 214, 221,
368
2010 Program Book